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Abstract. The utility for carbon-Carbon bond formation of a 
multi-enzyme system composed by recombinant
dihydroxyacetone kinase (DHAK) from Citrobacter 
freundii, the fructose bisphosphate aldolase from Rabbit
muscle (RAMA) and acetate kinase (AK) for ATP 
regeneration has been studied. Several aldehydes with great
structural diversity, including three α,β-unsaturated 
aldehydes, have been analyzed as acceptor substrates.  
It was found that α,β-unsaturated aldehydes bearing an
electron-withdrawing group in β position to the double bond
with trans configuration are good acceptors for RAMA in
this multi-enzyme system. 
Aldol reaction proceeds with excellent D-threo
enantioselectivity and the aldol adduct is obtained in a good 
overall yield. The L-threo and D-erythro enantiomers are 
also accessible from rhamnulose-1-phosphate aldolase 
(Rha-1PA) and fuculose-1-phosphate aldolase (Fuc-1PA) 
catalysed reactions respectively. 
Keywords: aldol reaction; aldolases; biotransformations; 
C-C bond formation; multi-enzyme processes  
 
1 Introduction 
Aldolases have been extensively used in 
chemoenzymatic syntheses because of their ability to 
catalyze the formation of C-C bonds with a high 
degree of stereochemical control. The main group of 
aldolases is the one that uses dihydroxyacetone 
phosphate (DHAP) as donor.[1] Their major drawback 
is their strict specificity for the donor substrate. 
Besides the limitations imposed by this fact, DHAP is 
expensive to be used in large-scale synthesis and 
labile at neutral and basic pH. Efforts to overcome 
the DHAP dependence of aldolases have involved the 
in situ formation of arsenate or borate esters of 
dihydroxyacetone (DHA) which act as phosphate 
ester mimics,[2] the modification of the substrate 
specificity of aldolases by in vitro Enzyme Directed 
Evolution strategies[3] and the use of newly 
discovered enzymes.[4] In addition to these efforts, an 
efficient method of DHAP preparation is still 
essential and several chemical and enzymatic routes 
of DHAP synthesis have been described.[5]  
A straightforward strategy for DHAP preparation 
is the kinase-catalysed DHA phosphorylation, using 
ATP as phosphoryl donor. This approach was first 
described in 1983 by Wong and Whitesides using the 
enzyme glycerol kinase.[6] ATP-dependent DHA 
kinases have also been used for the simple and 
efficient preparation of DHAP. Itoh et al.,[7] have 
shown that DHAK isoenzyme I, from 
Schizosaccharomyces pombe strain IFO 0354, is a 
useful biocatalyst for the production of DHAP. 
Our research group has described a multi-enzyme 
system for one-pot C-C bond formation,[8] based on 
the use of a recombinant ATP-dependent DHAK 
from Citrobacter freundii CECT 4626[9] for in situ 
DHAP formation and fuculose 1-phosphate aldolase 
(Fuc-1PA) for the catalysis of the aldol reaction. The 
multi-enzyme system was completed with the in situ 
regeneration of ATP from acetyl phosphate catalysed 
by acetate kinase (AK). This regeneration system 
allows the use of ATP in catalytic amounts and 
avoids the accumulation of ADP, which is a strong 
inhibitor of the DHAK activity. 
In our aim to broaden the scope of the multi-
enzyme system, we describe here its use with fructose 
1,6-bisphosphate aldolase from rabbit muscle 
(RAMA) for the catalysis of the aldol reaction of 
aldehydes with diverse chemical structures as 
acceptor substrates (Scheme 1). Among the aldehydes 
assayed three α,β-unsaturated aldehydes (compounds 
3i, 3j and 3l) were included despite it has been 
described that these aldehydes are not substrates of 
RAMA.[10]  
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Scheme 1. Multi-enzyme system for the facile aldol addition reaction between DHAP —in situ obtained by enzymatic 
phosphorylation of DHA— and different aldehydes, catalysed by RAMA. 
Interestingly, ethyl-3-methyl-4-oxocrotonate (3l) 
was efficiently accepted as substrate by RAMA in the 
context of this multi-enzyme system. Therefore, we 
focused on the study of the reaction with this 
aldehyde and explored if it is also substrate of l-
fuculose-1-phosphate aldolase (Fuc-1PA) and l-
rhamnulose-1-phosphate aldolase (Rha-1PA). 
Structure identification of the three aldol products 
obtained and the study of the acceptor influence on 
the steric outcome of the aldolases-mediated 
reactions are reported. 
2 Results and Discussion 
Optimization of the multi-enzyme system with 
RAMA 
In our previous paper,[8]  we described the 
performance of our multi-enzyme system employing 
a one-pot/one-step strategy. In this approach, all the 
necessary components for the enzymatic 
phosphorylation of DHA and the aldol addition are 
present at the beginning of the reaction. The main 
feature of this process is that the DHAP must be 
formed at the same rate as it is consumed by the 
aldolase.[8] Two conditions are necessary to ensure 
that this multi-enzyme system functions optimally: (i) 
the pH must be maintained at 7.5 and (ii) the 
aldolase/kinase activity ratio must be adjusted to 
avoid the accumulation of DHAP. In spite of the 
advantages of using acetyl phosphate as phosphoryl 
donor, the activity of the AK is sensitive to changes 
in pH. Thus, continuous maintenance of the pH to 7.5 
was needed to ensure the optimal functioning of the 
system. Since DHAP is unstable at pH 7.5, delicate 
adjustments of the activities of aldolase and/or 
DHAK were necessary to prevent the accumulation 
of DHAP and to minimise its non-enzymatic 
degradation. The optimum RAMA/DHAK activity 
ratio was calculated using acetaldehyde as acceptor. 
In our first experiment with this enzyme using a 
RAMA/DHAK ratio of 1/1.5, there was considerable 
accumulation of DHAP, but almost no formation of 
the aldol product after 1 hour. Thus, we decided to 
increase the RAMA/DHAK activity ratio to 4/1. 
Under these conditions, 23 μmol DHAP (23%) 
accumulated and only 9% of the aldol product was 
formed after 1 hour. At longer reaction times, the 
accumulation of DHAP increased but the amount of 
the aldol product remained constant. These results 
indicated that it was necessary to have an initial high 
RAMA/DHAK activity ratio and also that the 
stability of RAMA may be low under the reaction 
conditions. After several attempts, we established that 
the initial optimum RAMA/DHAK activity ratio was 
11.5/1. Since, the half-life of RAMA was 
approximately 5 hours under the reaction conditions, 
it was necessary to supply the reaction with an 
additional aliquot of 12 U of aldolase after 3 hours of 
reaction (see the Supporting Information). 
Screening of the synthetic applicability of the 
multi-enzyme system. One-pot/one-step 
approach 
Under these conditions, reactions with the selection 
of aldehydes (3a-3l, Scheme 1) were carried out in a 
0.1 mmol of DHA scale in a one-pot/one-step 
protocol. In this initial screening, yields were not 
optimized. For some acceptors the RAMA/DHAK 
activity ratio had to be experimentally optimised. The 
degree of substrate conversion to product was 
measured using the retro-aldol activity of the 
aldolase.[11] The results could be grouped into three 
categories (Table 1):  
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Table 1. Formation of aldols 4a-4l catalysed by the DHAK/RAMA multi-enzyme system.  
 One-pot/one-step One-pot/two-steps 
Aldehyde Aldol formation [%] DHA consumption [%] Aldol formation [%] DHAP accumulation [%] 
3a 53.2 98.0   
3b 7.8 97.4 4.5 95.0 
3c 63.3 95.0 61.5 >95.0 
3d 52.2 96.0   
3e 10.8 98.2 9.6 95.0 
3f[a] 0.0 0.0 58.9 >95.0 
3g[b] 70.6 97.1   
3h 32.1 98.0   
3i 1.5 99.4 4.1 95.0 
3j[c] 1.7 22.8 3.0 >95.0 
3k 70.5 95.1 81.0 >95.0 
3l 7.4 61.8 48.7 >95.0 
[a] Aldehyde is provided as a 50% dilution in benzylalcohol (reaction contains 3.3% of benzyl alcohol). [b] Reaction 
contains 10% of DMSO. [c] Reaction contains 5% of DMSO. 
(i) those where the phosphorylation of DHA 
worked properly, namely, the percentage of DHA 
consumption ranged between 95 and 100% and 
percentage of aldol product formation was over 25% 
(aldehydes 3a, 3c, 3d, 3g, 3h and 3k); (ii) those 
where the extent of DHA phosphorylation was almost 
complete (95-100%), but the aldol formation was 
lower than 25% (aldehydes 3b, 3e and 3i); and (iii) 
those where the extent of DHA phosphorylation was 
lower than 90% or even null reaction (aldehydes 3f, 
3j and 3l). 
As expected, none of the three α,β-unsaturated 
aldehydes was substrate of the RAMA catalysed 
reaction. In the case of aldehyde 3i, the result 
obtained —as for other aldehydes belonging to the 
second category— can be explained because this 
compound is poor substrate for the aldolase however, 
in the case of aldehyde 3j and even 3l, the lack of 
reaction with the aldolase could be due to the low 
amount of DHAP formed. In fact, the results 
belonging to the third category show clearly that the 
phosphorylation system had not worked properly 
either because the aldehydes themselves or a 
component in the reaction medium interfered or 
inhibited the DHAK or the AK. In this sense, the 
presence of benzyl alcohol in the reaction mixture 
with aldehyde 3f could explain the results obtained 
with this substrate. 
One-pot/two-step approach 
In order to overcome the failures found in the 
reactions of the third category, we decided to explore 
a one-pot/two-steps strategy and apply it also to the 
second category reactions and to those aldehydes that 
were in the limit of the first category (aldehydes 3c 
and 3k). With this protocol, only the components for 
the enzymatic phosphorylation of DHA are added at 
the beginning of the reaction, allowing DHAP to 
accumulate. When at least 95% of DHAP was formed, 
we reduced the pH to 6.8 ―at this pH the degradation 
rate of DHAP decreases significantly (see the 
Supporting Information)― and then, both aldolase 
and aldehyde were added to initiate the aldol addition 
as a second step. 
When using this strategy, we were able to restore 
the functionality of the multi-enzyme system and, in 
most instances of the third category reactions, the 
percentage of the aldol formation increased 
significantly (Table 1). Thus, aldol 4f that was 
unaccessible with the one-pot/one-step approach, can 
be obtained in good yield using this protocol. 
However, the most interesting result was the obtained 
with the activated α,β-unsaturated aldehyde 3l that in 
this approach performed as a good substrate for 
RAMA. On the other hand, the use of the one-
pot/two-steps approach produced no significant 
increase in the percentage of aldol formation in the 
reactions belonging to the second category, 
confirming that these aldehydes are poor substrates 
for RAMA. However, when the aldehyde is a good 
substrate for RAMA applying the one-pot/two-step 
approach the yield of aldol can be improved, like in 
the case of 4k which yield increased from 70% to 
81%. 
Those reactions that gave a percentage of aldol 
formation exceeding 25%, were repeated in a 0.3 
mmol of DHA scale, the aldol products were purified 
by precipitation with barium salt[12] and their identity 
established by NMR analysis. Thus, we could 
validate that the α,β-unsaturated aldehyde 3l was 
accepted as substrate by RAMA in the context of this 
multi-enzyme system yielding the aldol product 4l. 
α,β-Unsaturated aldehyde 3l as substrate of 
RAMA 
In order to prove the synthetic utility of this approach, 
we repeated the reaction with aldehyde 3l in a 3 
mmol of DHA scale. In a first attempt, we used 
proportionally, lower amount of RAMA than in the 
reaction at 0.3 mmol scale. In these conditions we 
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obtained 51.4% of aldol 4l after 26 h of reaction. 
Since some degree of RAMA precipitation was 
observed, it was necessary to add more enzyme along 
the reaction time. This precipitation was due to the 
presence of 3l, since in its absence protein 
precipitation was not observed. In subsequent 
reactions, we increased the amount of RAMA and the 
reaction was completed in 8 h with 60% of aldol 
product formation. The phosphorylated aldol adduct 
4l was purified by HPLC with 54% overall yield. 1H 
and 13C NMR of the purified aldol showed signals 
almost exclusively for one diastereoisomer, 
presumably the one corresponding to syn 
configuration of the hydroxyl groups in the new 
stereogenic centers (Figure 1). 
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Figure 1. 1H (A) and 13C (B) NMR spectra of aldol 4l. 
To distinguish between the two syn enantiomers, 
we applied the enzymatic assay described by Sheldon 
and co-workers based on the reversibility of the aldol 
reaction.[13] Aldol 4l was submitted to retro-aldol 
reaction catalysed by RAMA, Rha-1PA and Fuc-1PA 
(Figure 2). 
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Figure 2. Enzymatic determination of the stereoisomers 
presents in aldol 4l. Retro-aldol reaction catalysed by 
RAMA (—); Rha-1PA (---) and Fuc-1PA  
More than 95% of the aldol adduct was cleaved by 
RAMA (D-threo configuration) and only about 4% 
was cleaved by Rha-1PA (L-threo configuration). No 
reaction was observed with Fuc-1PA (D-erythro 
configuration) and, althougth we could not performed 
the reaction with tagatose bisphosphate aldolase (L-
erythro configuration), the presence of stereoisomer 
with the corresponding configuration was discarded 
since the the sum of the products with D- and L-threo 
configuration represented the 100% of aldol 4l. These 
results clearly showed that the main compound 
obtained was a D-threo configured aldol and that the 
reaction proceeded with high enantioselectivity. 
α,β-Unsaturated aldehydes are not substrates of 
RAMA because the electron delocalization through 
the double bond reduce the positive charge in the 
carbonyl carbon precluding the nucleophilic attack of 
the enamine intermediate formed from the ketone 
substrate and the enzyme (Scheme 2). 
 
Scheme 2. 
In the case of the aldehyde 3l, the presence of the 
ester group introduces an additional resonance 
structure with a negative charge in the carbonyl 
oxygen of the ester and a positive charge in alpha 
position of carbonyl of the aldehyde (Scheme 3). 
 
Scheme 3. Resonance structures of the aldehyde 3-methyl-
4-oxocrotonate (3l). 
Thus, the presence of an electron-withdrawing 
substituent must activate the aldehyde carbonyl group 
increasing its reactivity. This effect is in agreement 
with the general observation by Whiteside and co-
workers[10] in which electron-withdrawing groups 
activated the carbonyl group against the nucleophilic 
attack increasing, therefore, its reactivity. 
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Synthesis of the L-threo and D-erythro 
enantiomers of 4l via Rha-1PA and Fuc-1PA 
catalysed reaction 
Since the aldol adduct 4l is a highly functionalized 
molecule and, therefore, of interest in organic 
synthesis, we decided to obtain their enantiomers L-
threo and D-erythro accessible via Rha-1PA and Fuc-
1PA catalysed reaction respectively. Reaction 
conditions were similar to those described for 4l. The 
highest yield achieved for aldol adduct L-threo-4l, 
was 60% after 6 h of reaction. Aldehyde 3l was a 
poor substrate for Fuc-1PA. In this case the 
maximum yield achieved was only 33% after 20 h of 
reaction. 1H and 13C NMR of the isolated aldols L-
threo-4l and D-erythro-4l clearly showed that the 
products were mixtures of two diaestereoisomers 
(Figure 3). 
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Figure 3. 1H (A, B) and 13C (C, D) NMR spectra of 
isolated products from Rha-1PA (A, C) and Fuc-1PA (B, 
D) catalysed reactions. 
One group of the signals was identical to that 
previously assigned to diastereoisomer syn, therefore 
the other group of signals must correspond to the anti 
diastereoisomer. As expected, in the reaction 
catalysed by Rha-1PA the major compound is the syn 
diastereoisomer with a syn:anti ratio of 76:24. In the 
Fuc-1PA catalysed reaction the syn:anti ratio is 
reversed (32:68) and the anti diastereoisomer is the 
major compound. Retro-aldol analysis of compounds 
L-threo-4l and D-erythro-4l, showed that only the 
enantiomers L-threo (major product in Figure 2A) 
and D-erythro (major product in Figure 2B) were 
presents in the samples. Although these results are 
consistent with the natural stereochemistry of these 
enzymes, they also show that in these cases the aldol 
reaction proceeds with lower enantioselectivity 
control that in the RAMA catalysed reaction. 
Conclusion 
In conclusion, the described multi-enzyme system is 
robust enough to be used with the three synthetically 
useful DHAP-dependent aldolases and with a great 
variety of aldehydes. The possibility to apply one-
step or two-steps strategies, make the system 
sufficiently flexible to be able to work under different 
reaction conditions such as the presence of co-
solvents. Interestingly, within the frame of our studies 
of this multi-enzyme system we have found that an 
α,β-unsaturated aldehyde bearing an electron-
withdrawing group in β position to the double bond 
with trans configuration is good acceptor for RAMA. 
Aldol addition catalysed by this enzyme proceeds 
with excellent D-threo enantioselectivity and good 
conversion. The L-threo and D-erythro enantiomers 
are also accessible in good yield from Rha-1PA and 
in moderate one from Fuc-1PA catalysed reactions 
respectively. In both cases, the reaction proceeds with 
lower enantioselectivity than that of RAMA catalysed 
reaction and a mixture of L-threo and D-erythro 
enantiomers were obtained, being in each case the 
major one the corresponding to the natural 
stereochemical preferences of each enzyme. The 
aldol products are functionalized compounds that can 
be useful intermediates in organic synthesis. 
Experimental Section 
General Remarks 
1H and 13C NMR spectra, using D2O as solvent, were 
recorded on a Varian SYSTEM 500 spectrometer equipped 
with a 5 mm HCN cold probe with field z-gradient, 
operating at 500.13 and 125.76 MHz for 1H and 13C, 
respectively. The sample temperature was maintained 
constant at 298 K. One-dimensional NMR experiments 
were performed using standard Varian pulse sequences. 
Two-dimensional [1H, 1H] NMR experiments (gCOSY and 
TOCSY) were carried out with the following parameters: a 
delay time of 1 s, a spectral width of 3000 Hz in both 
dimensions, 4096 complex points in t2 and 4 transients for 
each of 256 time increments, and linear prediction to 512. 
The data were zero-filled to 4096 × 4096 real points. Two-
dimensional [1H-13C] NMR experiments (gHSQC and 
gHMBC) used the same 1H spectral window, a 13C spectral 
windows of 15 000 Hz, 1 s of relaxation delay, 1024 data 
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points, and 256 time increments, with a linear prediction to 
512. The data were zero-filled to 4096 × 4096 real points. 
Typical numbers of transients per increment were 4 and 16, 
respectively. UV/Visible spectra were recorded on a 
SpectraMax Plus 384 spectrophotometer at 25 ºC. TLC 
was performed on silica-gel plates(GF254 Merck) with 
fluorescent indicator and detection was carry out by 
charring with Ce2MoO4. HPLC analyses were carried out 
on a chromatograph JASCO, Dual Gradient Pump, with 
UV/VIS detector. Optical rotations were determined on a 
Perkin Elmer 241 MC polarimeter for D2O solutions and 
are given in 10-1 deg·cm2·g-1. Aldehydes 3a-3l were 
purchased from Sigma-Aldrich or Fluka. Fructose-1,6-
bisphosphate aldolase from rabbit muscle (RAMA), acetate 
kinase (AK) and α-glycerophosphate dehydrogenase/triose 
phosphate isomerase (α-GDH/TIM) were purchased from 
Sigma-Aldrich. Rha-1PA, Fuc-1PA and DHAK were 
cloned in our laboratory.[9, 14] All other chemicals were 
purchased from commercial sources as reagent grade. 
General Protocol for One-pot/One-step 
Reactions 
The one-pot/one-step reactions were carried out in HEPES 
buffer (3 mL, 20 mM pH 7.5) containing DHA (0.1 mmol), 
aldehyde (0.15 mmol), acetyl phosphate (0.2 mmol) and 
MgSO4 (25 μmol), DHAK (1 U), AK (6 U) and RAMA 
(11.5 U). After 3 h of reaction an additional amount of 
RAMA (12 U) was added due to the instability of the 
aldolase. To reactions with aldehydes 3g and 3j 10% and 
5% of DMSO was added respectively to improve their 
solubility. Aldehyde 3f was supplied in a 50 % solution in 
benzylalcohol that yield a 3.3% of benzylalcohol in the 
reaction mixture. Reactions were initiated upon addition of 
ATP (6.8 μmol) and their progress were 
spectrophotometrically followed. A continuous pH 
adjustment to 7.5 during the reaction course was needed to 
keep the ATP regeneration system working. 
General Protocol for One-pot/Two-step 
Reactions 
The one-pot/two-steps reaction were carried out in HEPES 
buffer (2 mL, 20 mM, pH 7.5) containing DHA (0.1 mmol), 
acetyl phosphate (0.2 mmol), MgSO4 (25 μmol), DHAK 
(6.5 U) and AK (6 U). The reactions were initiated upon 
addition of ATP (6.8 μmol). When DHAP accumulation 
was higher than 95%, the pH was adjusted to 6.8 and water 
(1 mL) containing the corresponding aldehyde (0.15 
mmol) and RAMA (11.5 U) was added. As before, after 3 
h of reaction more RAMA (12 U) was added. For 
aldehydes 3g and 3j 10% and 5% of DMSO respectively 
was added. The reaction progress was 
spectrophotometrically followed. For reactions at 0.3 
mmol of DHA scale, the concentration of reactive were 
kept. To initiate the aldol reaction RAMA (51.6 U) was 
added. Additional aliquots of RAMA (12.3 U) were added 
after 1 h and 3 h of reaction. 
Tracking of reaction progress 
The amount of DHAP formed was quantified by an 
enzymatic assay based in the reduction of DHAP, 
catalysed by the α-GDH with concomitant oxidation of 
NADH to NAD+ monitoring the decrease of absorbance at 
340 nm ( 340NADHε = 6220 cm-1·M-1).[11] The assays were run 
at room temperature, measuring the absorbance at 340 nm 
for 15 minutes in a reaction mixture (1 mL) containing the 
reaction aliquot, Tris-HCl (40 mM, pH 8.0), NADH (0.2 
μmol) and α-GDH/TIM (2 U). For the measurement of the 
DHA consumption, DHAK (0.375 U), ATP (5 μmol) and 
MgSO4 (3.75 μmol) were added to the reaction mixture. 
The accumulation of the aldol product was measured using 
the retro-aldol activity of the aldolase (0.05 U). 
5-Deoxy-D-threo-pent-2-ulose 1-phosphate 
(4a) 
2 isomers (3:1) Major isomer: 1H NMR (500 MHz, D2O, 
298 K): δ  4.54 (d, 1H, J= 5.9 Hz, H-1A), 4.46 (d, 1H, J= 
J= 6.2 Hz, H-1B); 4.18 (d, 1H, J= 2.3 Hz, H-3); 4.10 (dq, 
1H, J= 6.6, 2.3 Hz, H-4), 1.07 (d, 3H, J= 6.6 Hz, CH3-5); 
13C NMR (125 MHz, D2O, 298 K): δ 211.6 (C-2), 78.5 (C-
3), 67.9 (C-4), 67.7 (C-1), 18.4 (C-5). Minor isomer: 1H 
NMR (500 MHz, D2O, 298 K): δ  4.50 (d, 1H, J= 6.2 Hz, 
H-1A), 4.42(d, 1H, J= J= 6.2 Hz, H-1B); 4.24 (d, 1H, J= 4.3 
Hz, H-3); 4.0-3.9 (m, 1H, 2.3 Hz, H-4), 0.96 (d, 3H, J= 6.6 
Hz, CH3-5). 
5-Deoxy-5-ethyl-D-threo-pent-2-ulose 1-
phosphate (4c) 
2 isomers (10:1) Major isomer: 1H NMR (500 MHz, D2O, 
298 K): δ  4.55 (dd, 1H, J= 18.7, 6.1 Hz, H-1A), 4.44 (dd, 
1H, J= 18.7, 6.1 Hz, H-1B); 4.22 (d, 1H, J= 2.1 Hz, H-3); 
3.87 (dt, 1H, J= 7.0, 2.1 Hz, H-4), 1.4-1.3 (m, 2H, CH2-5), 
1.3-1.1 (m, 2H, CH2-6), 0.71 (t, 3H, J= 7.4 Hz, CH3-7); 13C 
NMR (125 MHz, D2O, 298 K): δ 212.2 (C-2), 77.6 (C-3), 
71.5 (C-4), 68.1 (C-1), 34.5 (C-5), 18.5 (C-6), 13.4 (C-7). 
5-Deoxy-5-propyl-D-threo-pent-2-ulose 1-
phosphate (4d) 
1H NMR (500 MHz, D2O, 298 K): δ  4.60 (dd, 1H, J= 18.8, 
5.9 Hz, H-1A), 4.50 (dd, 1H, J= 18.8, 5.9 Hz, H-1B); 4.27 
(s, 1H, H-3); 3.90 (t, 1H, J= 7.1 Hz, H-4), 1.5-1.4 (m, 2H, 
CH2-5), 1.3-1.1 (m, 4H, CH2-6, CH2-7), 0.72 (t, 3H, J= 6.9 
Hz, CH3-8); 13C NMR (125 MHz, D2O, 298 K): δ 212.1(C-
2), 77.6 (C-3), 71.9 (C-4), 68.1 (C-1), 32.1 (C-5), 27.4 (C-
6), 22.1 (C-7), 13.6 (C-8). 
5-Deoxy-5-phenyl-D-threo-pent-2-ulose 1-
phosphate (4f) 
2 isomers (8:1) Mayor isomer: 1H NMR (500 MHz, D2O, 
298 K): δ 7.2-7.1 (m, 5H, Ar), 4.53 (d, 1H, J= 6.3 Hz, H-
1A), 4.49 (d, 1H, J= 6.3 Hz, H-1B), 4.2-4.1 (m, 2H, H-3, H-
4), 2.9-2.7 (m, 2H, CH2-5); 13C NMR (125 MHz, D2O, 298 
K): δ 211.9 (C-2), 138.2 (Cq-Ar), 129.3-128.4 (C-Ar), 77.1 
(C-3), 73.1 (C-4), 70.8 (C-1), 39.8-38.2 (C-5). 
5-O-Benzyl-D-threo-pent-2-ulose 1-phosphate 
(4g) 
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1H NMR (500 MHz, DO, 298 K): δ 7.2-7.1 (m, 5H, Ar), 
4.52 (dd, 1H, J= 18.5, 5.8 Hz, H-1A), 4.40 (dd, 1H, J= 18.5, 
5.8 Hz, H-1B); 4.4-4.3 (m, 2H, CH2Ph), 4.1-4.0 (m, 1H, H-
3), 3.5-3.4 (m, 1H, H-4), 3.5-3.4 (m, 1H, H-4),3.27 (d, 2H, 
J= 4.9 Hz); 13C NMR (125 MHz, D2O, 298 K): δ 212.3 (C-
2), 129.5 (Ar), 129.3 (Ar), 128.9 (Ar), 128.6 (Ar), 75.5 (C-
1); 73.1 (C-5); 72.4 (CH2Ph); 70.5 (C-4); 70.2 (C-3). 
5-Deoxy-5-(methylthio)methyl-D-threo-pent-2-
ulose 1-phosphate (4h) 
1H NMR (500 MHz, D2O, 298 K): δ  4.55 (dd, 1H, J= 18.8, 
6.6 Hz, H-1A), 4.45 (dd, 1H, J= J= 18.8, 6.6 Hz, H-1B); 
4.28 (d, 1H, J= 2.2 Hz, H-3); 4.05 (ddd, 1H, J= 14.4, 11.5, 
9.2 Hz, H-4), 2.5-2.4 (m, 2H, H-6), 1.95 (s, 3H, Me), 1.8-
1.7 (m, 2H, H-5); 13C NMR (125 MHz, D2O, 298 K): δ 
211.5 (C-2), 77.7 (C-3), 70.4 (C-4), 68.1 (C-1), 29.6 (C-6), 
23.5 (C-5); 14.3 (Me). 
5-O-Methyl-5-methoxy-D-threo-pent-2-ulose 1-
phosphate (4k) 
1H NMR (500 MHz, D2O, 298 K): δ  4.54 (dd, 1H, J= 18.8, 
6.1 Hz, H-1A), 4.48 (dd, 1H, J= 18.8, 6.1, H-1B), 4.42 (m, 
1H, H-3), 4.34 (d, 1H, J= 7.5 Hz, H-5), 3.9-3.8 (m, 1H, H-
4), 3.30 (s, 3H, OMe), 3.28 (s, 3H, OMe); 13C NMR (125 
MHz, D2O, 298 K): δ 211.3 (C-2), 105.1 (C-5), 75.1 (C-3), 
70.9 (C-4), 68.2 (C-1), 56.1(OMe), 54.8 (OMe). 
(E)-5,6-Dideoxy-6-(ethoxycarbonyl)-5-methyl-
D-threo-pent-5-en-2-ulose 1-phosphate (4l) 
Enzymatic synthesis of 4l was carried out by the one 
pot/two steps approach as described before but in a 3 mmol 
of DHA scale. Thus, the reaction mixture (60 mL) 
contained: HEPES pH 7,5 (20 mM), DHA (3 mmoles), 
MgSO4 (0,75 mmoles), Acetil-P (6 mmoles), DHAK (66 
U) y AK (180 U). The reaction was initiated upon addition 
of ATP (0.2 mmol). When DHAP accumulation was 
higher than 95%, the pH was adjusted to 6.8 the aldehyde 
3l (4.5 mmoles) and RAMA (246 U) were added. After 6 h 
of reaction another 123 U of RAMA were added. 
Compound 4l was purified by HPLC (see the Supporting 
Information); [α]D25 - 1.67 (c 0,9, D2O); 1H NMR (400 
MHz, D2O, 298 K): δ  5.85 (s, 1H, H-7), 4.72 (dd, 1H, J= 
18.3, 7.5 Hz, H-1A), 4.63 (dd, 1H, J= 18.3, 7.5 Hz, H-1B), 
4.52 (d, 1H, J= 2.2 Hz, H-3), 4.48 (s, 1H, H-4), 4.00 (c, 2H, 
J= 7.1 Hz, H-9), 1.91 (s, 3H, CH3-6), 1.08 (t, 3H, J= 7.1 
Hz, CH3-10); 13C NMR (100 MHz, D2O, 298 K): δ 208.7 
(C-2), 168.9 (C-8), 157.3 (C-5), 116.0 (C-7), 75.5 (C-3), 
75.1 (C-4), 69.1 (C-1), 61.3 (C-9), 15.5 (C-6), 13.5 (C-10); 
EM (IES-MFE): m/z 311.0536 [M]+; C10H15O9P2- 
(310.0465): calcd C 38.47, H 5.49; found: C, 38.61; H, 
5.75. 
L-threo-4l 
The procedure was similar to that described for 4l. 42 U of 
Rha-1PA were added at the beginning of the reaction. 
After 3h of reaction other 30 U of Rha-1PA were added; 
1H NMR (400 MHz, D2O, 298 K): δ  5.73 (s, 1H, H-7), 
4.71 (dd, 1H, J= 18.3, 7.5 Hz, H-1A), 4.62 (dd, 1H, J= 18.3, 
7.5 Hz, H-1B), 4.31 (d, 1H, J= 5.9 Hz, H-3), 4.18 (d, 1H, 
J= 6.1 Hz, H-4), 3.90 (c, 2H, J= 7.1 Hz, H-9), 1.99 (s, 3H, 
CH3-6), 1.08 (t, 3H, J= 7.1 Hz, CH3-10); 13C NMR (100 
MHz, D2O, 298 K): δ 208.7 (C-2), 168.6 (C-8), 156.2 (C-
5), 117.7 (C-7), 76.9 (C-4), 75.2 (C-3), 69.4 (C-1), 61.3 
(C-9), 15.7 (C-6), 14.5 (C-10); EM (IES-EM): m/z 311.0 
[M]+, 623.2 (2x[M]+). 
D-erythro-4l 
The procedure was similar to that described for 4l. 110 U 
U of Fuc-1PA were added at the beginning of the reaction. 
After 6h of reaction other 40 U of Fuc-1PA were added; 1H 
NMR (400 MHz, D2O, 298 K): δ  5.84 (s, 1H, H-7), 4.72 
(dd, 1H, J= 18.3, 7.5 Hz, H-1A), 4.63 (dd, 1H, J= 18.3, 7.5 
Hz, H-1B), 4.51 (d, 1H, J= 2.2 Hz, H-3), 4.48 (s, 1H, H-4), 
4.00 (c, 2H, J= 7.1 Hz, H-9), 1.91 (s, 3H, CH3-6), 1.08 (t, 
3H, J= 7.1 Hz, CH3-10); 13C NMR (100 MHz, D2O, 298 
K): δ 208.7 (C-2), 168.9 (C-8), 157.3 (C-5), 116.0 (C-7), 
75.5 (C-3), 75.1 (C-4), 69.1 (C-1), 61.3 (C-9), 15.5 (C-6), 
13.5 (C-10). EM (IES-EM): m/z 311.0 [M]+, 623.2 
(2x[M]+). 
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